tert-Butyl (2-oxo-3-(trifluoromethyl)piperidin-3-yl)carbamate

Catalog No.: 
ACVUIB752
CAS No.: 
195196-07-7
Molecular Formula: 
C11H17F3N2O3
Molecular Weight: 
282.26
tert-Butyl (2-oxo-3-(trifluoromethyl)piperidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%
250mg98%
1g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (2-oxo-3-(trifluoromethyl)piperidin-3-yl)carbamate
IUPAC Nametert-butyl (2-oxo-3-(trifluoromethyl)piperidin-3-yl)carbamate
MDL No.MFCD07779909
Molecular FormulaC11H17F3N2O3
Molecular Weight282.26
SMILESO=C(OC(C)(C)C)NC1(C(F)(F)F)C(NCCC1)=O
InChI KeyNIUWIGGGPOVCFV-UHFFFAOYSA-N
SynonymTERT-BUTYL 2-OXO-3-(TRIFLUOROMETHYL)PIPERIDIN-3-YLCARBAMATE;tert-butyl N-[2-oxo-3-(trifluoromethyl)piperidin-3-yl]carbamate;Carbamic acid, [2-oxo-3-(trifluoromethyl)-3-piperidinyl]-,1,1-dimethylethyl ester;tert-butyl N-[2-oxo-3-(trifluoromethyl)-3-piperidyl]carbamate;Carbamic acid, N-[2-oxo-3-(trifluoromethyl)-3-piperidinyl]-, 1,1-dimethylethyl ester
CAS No.195196-07-7
PubChem CID15817296

Safety Data

Pictogram
Toxic
Signal Word
Danger
Precautionary Statement(s)
P264-P270-P301+P312-P330

Synthetic Route by SureRoute

1. ACVUIB752 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVUIB752 route product structure diagram
    ACVUIB752195196-07-7
Inquiry

2. ACVUIB752 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVUIB752 route product structure diagram
    ACVUIB752195196-07-7
Inquiry

3. ACVUIB752 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVUIB752 route product structure diagram
    ACVUIB752195196-07-7
Inquiry

Comments (0)